Articles
Systematic Literature Review (SLR) of Disease Burden Related to First-Line (1L) Unresectable, Locally Advanced, or Metastatic Esophageal Squamous Cell Carcinoma (ESCC)
- Journal/Conference:
- 2024-11, ISPOR Europe 2024, Barcelona, Spain
- Author(s):
- Smyth E1, Sibiga A2, Nehdi AN2, Krishna A3, Kim K2, Coaquira Castro J4, Priedane E5, Zhan L4 1Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, UK, 2EVERSANA, Burlington, ON, Canada, 3EVERSANA India Private Limited, Mumbai, MH, India, 4BeiGene USA, Inc., Emeryville, CA, USA, 5BeiGene UK, Ltd., London, LON, UK
- Publication Date:
- Value in Health, Volume 27, Issue 12, S2 (December 2024)
- Topic/Therapeutic Area:
- Gastroenterology, Oncology
- Condition:
- Cancer
Coding and Reimbursement Assessment for Potential Acquisition
Cardiovascular Disease State Assessment with EVERSANA Management Consulting
The client developed predictive and prognostic tests for determining the risk of cardiovascular disease in various patient groups. Before further investing in product development, the client needed to assess the potential for success in CVD by…
Integrated Brand Planning with EVERSANA MANAGEMENT CONSULTING
Optimizing Patient Journey with EVERSANA MANAGEMENT CONSULTING
Assess MPS II Diagnosis and Treatment Referral Pathways and Identify Potential Patients via Predictive Modeling
Top features from the designed predictive model align well with the human phenotype ontology associations for MPS II. The top treatment centers across the country for MPS II patients based on patient volume and mapped referrals.
Finding APDS Patients Using Predictive Models
Summary of typical APDS symptoms (left) and importance of features output by the predictive model for patients over the age of 12 (right).
Machine Learning Model Using Insurance Claims Data to Help Predict ALS Diagnosis
Poster presented at Mayo Clinic Annual Conference 2019 outlining model performance and feature importance in the prediction of future ALS diagnosis.